tradingkey.logo
tradingkey.logo
Search

Xilio Therapeutics Inc

XLO
Add to Watchlist
9.110USD
+0.030+0.33%
Close 07-31 16:00ETQuotes delayed by 15 min
52.68MMarket Cap
LossP/E TTM

XLO Financials

See Xilio Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Xilio Therapeutics Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.58/-0.66
Revenue / Forecast
12.65M/8.52M
Period
FY2025 Earnings
Revenue(YoY)
43.77M
589.88%
EPS(YoY)
-4.19
72.49%
Analyst Rating
STRONG BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-228.25%-0.58
571.65%0.95
48.84%-0.11
31.86%-0.16
71.19%-0.18
68.44%-0.20
63.70%-0.22
65.79%-0.24
25.34%-0.62
21.82%-0.64
---0.61
---0.70
---0.83
---0.82
---2.40
----
----
----
----
----
Revenue
331.67%12.65M
693.85%13.69M
742.51%19.07M
242.98%8.08M
--2.93M
--1.72M
--2.26M
--2.36M
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
28.16%-9.53M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.20M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
5.16%-19.70M
-9.66%-16.25M
-101.40%-23.18M
Net Margin
83.36%-75.34%
109.97%75.70%
86.21%-85.42%
66.83%-195.99%
---452.73%
---759.45%
---619.53%
---590.79%
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
-100.00%0.00%
----
-100.00%0.00%
-22.99%5.44%
--6.37%
--7.74%
--7.37%
--7.06%
--6.21%
----
----
----
----
----
Revenue
331.67%12.65M
693.85%13.69M
742.51%19.07M
242.98%8.08M
--2.93M
--1.72M
--2.26M
--2.36M
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-1.88%-14.11M
13.16%-11.84M
86.97%-1.93M
2.10%-14.37M
16.25%-13.85M
24.83%-13.63M
14.73%-14.80M
27.05%-14.67M
29.70%-16.54M
21.74%-18.13M
14.08%-17.36M
18.07%-20.12M
-10.85%-23.53M
-18.46%-23.17M
-26.60%-20.21M
-6.72%-24.55M
-28.47%-21.22M
5.04%-19.56M
-9.15%-15.96M
-100.99%-23.01M
Net Profit
28.16%-9.53M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.20M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
5.16%-19.70M
-9.66%-16.25M
-101.40%-23.18M
Current assets
65.46%154.21M
140.77%145.03M
96.01%124.09M
58.59%123.72M
34.71%93.20M
25.16%60.23M
-1.82%63.31M
-0.53%78.01M
-28.66%69.19M
-61.34%48.13M
-54.69%64.48M
-51.89%78.42M
-46.45%96.98M
-38.53%124.50M
34.80%142.31M
30.84%163.01M
26.97%181.09M
--202.52M
--105.57M
--124.59M
Total current liabilities
-9.82%42.96M
106.42%56.27M
48.34%56.40M
37.83%53.26M
50.84%47.64M
70.84%27.26M
124.60%38.02M
137.16%38.64M
95.02%31.58M
-24.44%15.96M
0.52%16.93M
-8.31%16.29M
32.47%16.19M
65.28%21.12M
30.85%16.84M
-16.59%17.77M
-24.97%12.22M
--12.78M
--12.87M
--21.30M
Total assets
57.63%163.49M
117.64%154.69M
79.08%133.69M
48.89%133.81M
25.55%103.72M
16.66%71.08M
-4.09%74.66M
-2.69%89.87M
-25.91%82.61M
-56.22%60.93M
-50.55%77.84M
-48.15%92.36M
-43.21%111.50M
-36.18%139.16M
30.39%157.41M
27.21%178.13M
24.00%196.35M
--218.06M
--120.72M
--140.02M
Total liabilities
-2.23%90.94M
123.30%119.41M
164.12%141.79M
124.50%126.74M
63.63%93.02M
121.91%53.48M
111.82%53.68M
125.99%56.46M
112.80%56.84M
-28.10%24.10M
-18.55%25.34M
-26.33%24.98M
-11.64%26.71M
2.72%33.52M
-9.26%31.12M
-11.80%33.91M
-12.60%30.23M
--32.63M
--34.29M
--38.45M
Total equity
577.99%72.55M
100.44%35.27M
-138.60%-8.10M
-78.85%7.07M
-58.47%10.70M
-52.21%17.60M
-60.05%20.97M
-50.40%33.42M
-69.61%25.77M
-65.14%36.83M
-58.43%52.50M
-53.28%67.38M
-48.96%84.79M
-43.03%105.65M
46.12%126.30M
41.98%144.22M
34.24%166.12M
--185.43M
--86.43M
--101.58M
Net operating income
-177.10%-22.34M
85.89%-2.00M
-27.96%-17.50M
-172.56%-14.48M
375.93%28.98M
-5.44%-14.16M
-2.27%-13.67M
220.39%19.95M
58.41%-10.50M
26.32%-13.43M
32.85%-13.37M
1.09%-16.57M
-21.19%-25.25M
-6.18%-18.22M
3.91%-19.91M
16.79%-16.76M
8.35%-20.84M
-35.08%-17.16M
-98.06%-20.72M
-151.13%-20.14M
Net investment
-2427.27%-556.00K
-1483.33%-95.00K
100.00%0.00
-1809.52%-401.00K
---22.00K
---6.00K
---9.00K
93.35%-21.00K
100.00%0.00
100.00%0.00
100.00%0.00
59.01%-316.00K
33.07%-170.00K
-34.66%-509.00K
-192.11%-333.00K
-76.03%-771.00K
-49.41%-254.00K
-250.00%-378.00K
80.14%-114.00K
38.83%-438.00K
Net financing
638.97%35.71M
337.28%35.87M
-9400.00%-285.00K
136.30%47.36M
406.50%4.83M
601.96%8.20M
99.87%-3.00K
2120.46%20.04M
156.52%954.00K
-7680.95%-1.63M
-10063.64%-2.24M
-4623.81%-992.00K
-33660.00%-1.69M
-100.02%-21.00K
-107.31%-22.00K
93.98%-21.00K
-100.00%-5.00K
92560.80%115.83M
563.08%301.00K
---349.00K

FAQs

What is the total revenue of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its total revenue reached 43.77M, with a year-on-year change of 6.34M.

What are the current assets of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its current assets were 145.03M, with a year-on-year change of 140.77.

What are the total assets of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its total assets of Xilio Therapeutics Inc were 154.69M, with a year-on-year change of 117.64.

What are the total liabilities of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its total liabilities of Xilio Therapeutics Inc were 119.41M, with a year-on-year change of 123.30.

What is the total equity of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its total equity of Xilio Therapeutics Inc was 35.27M, with a year-on-year change of 100.44.

What is the net operating income of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its net operating income of Xilio Therapeutics Inc was -41.98M, with a year-on-year change of 29.61.

What is the net investment of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its net investment of Xilio Therapeutics Inc was -518.00K, with a year-on-year change of -1338.89.

What is the net financing of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its net financing of Xilio Therapeutics Inc was 87.78M, with a year-on-year change of 200.64.

What is the Earnings Per Share (EPS) of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.19, with a year-on-year change of 72.49.

What is the net income of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its net income was -35.04M, with a year-on-year change of 39.84.

What is the net margin of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its net profit margin was -80.05, with a year-on-year change of 91.28.

What is the Return on Equity (ROE) of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -132.53, with a year-on-year change of 38.07.

What is the Return on Assets (ROA) of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -31.04, with a year-on-year change of 64.83.

What is the operating profit of Xilio Therapeutics Inc?

According to Xilio Therapeutics Inc's FY2025 earnings report, its operating profit was -41.98M, with a year-on-year change of 29.61.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.